Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,081 to 2,100 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma. | Onco Targets Ther | 2021 | 33814917 | PubTator, text mining | PubMed |
| Validation of Polymorphisms Associated with the Risk of Radiation-Induced Oesophagitis in an Independent Cohort of Non-Small-Cell Lung Cancer Patients. | Cancers (Basel) | 2021 | 33810047 | PubTator, text mining | PubMed |
| Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML). | Cancers (Basel) | 2021 | 33807279 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells. | Int J Mol Sci | 2021 | 33806327 | PubTator, text mining | PubMed |
| T and B Lymphocyte Transcriptional States Differentiate between Sensitized and Unsensitized Individuals in Alpha-Gal Syndrome. | Int J Mol Sci | 2021 | 33804792 | PubTator, text mining | PubMed |
| Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies. | Genes (Basel) | 2021 | 33804731 | PubTator, text mining | PubMed |
| In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure? | Viruses | 2021 | 33803790 | PubTator, text mining | PubMed |
| Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas. | Cells | 2021 | 33803671 | PubTator, text mining | PubMed |
| Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy. | Cancers (Basel) | 2021 | 33801589 | PubTator, text mining | PubMed |
| An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo. | Vaccines (Basel) | 2021 | 33799516 | PubTator, text mining | PubMed |
| Construction of an immune-related LncRNA signature with prognostic significance for bladder cancer. | J Cell Mol Med | 2021 | 33797188 | PubTator, text mining | PubMed |
| Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining. | Front Oncol | 2021 | 33796453 | PubTator, text mining | PubMed |
| Research advances in chimeric antigen receptor-modified T-cell therapy (Review). | Exp Ther Med | 2021 | 33790993 | PubTator, text mining | PubMed |
| Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy. | Front Immunol | 2021 | 33790906 | PubTator, text mining | PubMed |
| Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs. | Transl Oncol | 2021 | 33789222 | PubTator, text mining | PubMed |
| Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism. | Stem Cell Res Ther | 2021 | 33781320 | PubTator, text mining | PubMed |
| Distinct genomic features across cytolytic subgroups in skin melanoma. | Cancer Immunol Immunother | 2021 | 33779796 | PubTator, text mining | PubMed |
| Novel Virulence Role of Pneumococcal NanA in Host Inflammation and Cell Death Through the Activation of Inflammasome and the Caspase Pathway. | Front Cell Infect Microbiol | 2021 | 33777832 | PubTator, text mining | PubMed |
| Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. | Front Oncol | 2021 | 33777778 | PubTator, text mining | PubMed |
| Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model. | Front Immunol | 2021 | 33777013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=105